Active ingredientLobeglitazoneCat. No. P-L078-001CAS 607723-33-1Family · Pharmaceutical analytical standards
Lobeglitazone
An antidiabetic of the thiazolidinedione (glitazone) class that activates PPAR alpha and gamma receptors and makes cells more sensitive to insulin: it was approved in South Korea in 2013 for type 2 diabetes. This family brings together the active ingredient and labelled standards.
Did you know?When it was approved, in July 2013, it was announced as the twentieth new drug developed in South Korea.
Go to the active ingredient →Active ingredientLobeglitazoneCat. No. P-L078-001CAS 607723-33-1
Isotopically labelledLobeglitazone-d4Cat. No. P-L078-002
Isotopically labelledLobeglitazone-d7Cat. No. P-L078-003No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.